The Scientist

» genome, culture and disease/medicine

Most Recent

image: In Times of Trouble

In Times of Trouble

By | August 1, 2012

Scientists share their experiences weathering extremely stressful events without letting their careers get completely derailed.

3 Comments

image: Island Disease

Island Disease

By | August 1, 2012

People living on islands in the Norwegian Sea suffer from an unusually high rate of certain genetic diseases and health issues, making the population ripe for research.

3 Comments

image: The Stuff of Nightmares

The Stuff of Nightmares

By | August 1, 2012

Researchers working in war-torn countries find hints to the molecular roots of posttraumatic stress disorder.

0 Comments

image: Bring On the Transparency Index

Bring On the Transparency Index

By | August 1, 2012

Grading journals on how well they share information with readers will help deliver accountability to an industry that often lacks it.

6 Comments

image: Predatory Publishing

Predatory Publishing

By | August 1, 2012

Overzealous open-access advocates are creating an exploitative environment, threatening the credibility of scholarly publishing.

32 Comments

image: Replacement Parts

Replacement Parts

By | August 1, 2012

To cope with a growing shortage of hearts, livers, and lungs suitable for transplant, some scientists are genetically engineering pigs, while others are growing organs in the lab.

18 Comments

image: Speaking of Science

Speaking of Science

By | August 1, 2012

August 2012's selection of notable quotes

3 Comments

image: Frankenlympics?

Frankenlympics?

By | July 26, 2012

Allowing athletes to enhance their performance by using genetic engineering to manipulate their DNA may become a reality of future Olympic Games.

2 Comments

image: Tissue on Chips Galore

Tissue on Chips Galore

By | July 26, 2012

The National Institutes of Health will fund 17 projects developing lab-on-a-chip applications to improve drug screening.

1 Comment

image: Cancer Drug Flushes Out HIV

Cancer Drug Flushes Out HIV

By | July 26, 2012

An approved cancer therapeutic makes hiding HIV susceptible to antiviral therapy.

1 Comment

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. Does Productivity Diminish Research Quality?
  3. How Plants Evolved Different Ways to Make Caffeine
  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech